INDICATION

Aptensio XR® (methylphenidate HCl extended-release) is a central nervous system (CNS) stimulant prescription medicine used for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in people 6 years of age and older.


Limitations of Use
Aptensio XR is not for use in children under 6 years of age because the safety and effectiveness have not been established.

IMPORTANT SAFETY INFORMATION

Aptensio XR is a federally controlled substance (CII) because it contains methylphenidate that can be a target for people who abuse prescription medicines or street drugs. Keep Aptensio XR in a safe place to protect it from theft. Never give your methylphenidate to anyone else, because it may cause death or harm to them. Selling or giving away Aptensio XR may harm others and is against the law. Tell your healthcare provider if you or your child have ever abused or been dependent on alcohol, prescription medicines, or street drugs.

Image portrays a 12-hour day when Aptensio XR is taken at 7:00 AM.

Ready to go with Aptensio XR for up to 12 hours

Once-daily Aptensio XR works in an hour and controls ADHD symptoms for up to 12 hours

In a study, patients were tested 1, 2, 3, 4.5, 6, 7.5, 9, 10.5, and 12 hours after taking Aptensio XR® (methylphenidate HCl extended-release). Improvements in ADHD symptoms were seen at each of these times.

IMPORTANT SAFETY INFORMATION

Aptensio XR is a federally controlled substance (CII) because it contains methylphenidate that can be a target for people who abuse prescription medicines or street drugs.